The Cluster for Nucleic Acid Therapeutics (CNATM) is one of the winners of the Cluster4Future competition organised by the German Federal Ministry of Education and Research (BMBF).
CNATM brings together scientists from the leading universities of LMU and TUM, the Universities of Regensburg and Würzburg, the Helmholtz Zentrum München and 17 companies from the Munich region to research nucleic acid therapeutics for the pharmaceutical market of the future.
The focus is on the translation of academic basic research into the pharmaceutical industry.
Company Details
- Employees
- 4
- Address
- Munich, De
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://cnatm.de/
- Keywords
- RNA, Therapeutics, RNA-Sequencing, Biotechnology, RNA-Delivery, RNA-Targeting, Drug development, Oligonucleotids, Research, Nucleosids, mRNA, Genetherapy.
- HQ
- Munich
Cnatm - Cluster For Nucleic Acid Therapeutics Munich Questions
Cnatm - Cluster For Nucleic Acid Therapeutics Munich's website is https://cnatm.de/
Cnatm - Cluster For Nucleic Acid Therapeutics Munich's LinkedIn profile is https://de.linkedin.com/company/cnatm
Cnatm - Cluster For Nucleic Acid Therapeutics Munich has
4 employees.
View email and phone details for 4
employees at Cnatm - Cluster For Nucleic Acid Therapeutics Munich.
Cnatm - Cluster For Nucleic Acid Therapeutics Munich's industry is
Research Services
Cnatm - Cluster For Nucleic Acid Therapeutics Munich's top competitors are
Rnatics,
Coriolis Pharma,
Eisbach Bio Gmbh,
Biom Biotech Cluster Development Gmbh,
Ethris,
Sitools Biotech Gmbh,
Rnhale,
Baseclick,
Isar Bioscience Gmbh,
Nanotemper Technologies.
Cnatm - Cluster For Nucleic Acid Therapeutics Munich's categories are Research Services
